Non-bacterial thrombotic endocarditis screening: Difference between revisions

	non-bacterial thrombotic endocarditis
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating non-bacterial thrombotic endocarditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X-ray
Echocardiography and Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Non-bacterial thrombotic endocarditis screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non-bacterial thrombotic endocarditis screening
CDC on Non-bacterial thrombotic endocarditis screening
Non-bacterial thrombotic endocarditis screening in the news
Blogs on Non-bacterial thrombotic endocarditis screening
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis screening

Latest revision as of 20:50, 6 August 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

There is insufficient evidence to recommend routine screening for non-bacterial thrombotic endocarditis.

There is insufficient evidence to recommend routine screening for non-bacterial thrombotic endocarditis.

@@ Line 2: / Line 2: @@
 {{non-bacterial thrombotic endocarditis}}
-{{CMG}}; {{AE}}{{Homa}}
+{{CMG}}; {{AE}}{{Aisha}}
 ==Overview==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
+There is insufficient evidence to recommend routine screening for non-bacterial thrombotic endocarditis.
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 ==Screening==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
+There is insufficient evidence to recommend routine screening for non-bacterial thrombotic endocarditis.
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-*[Condition 1]
-*[Condition 2]
-*[Condition 3]
 ==References==